Cleared Traditional

K930685 - TECHNICON H* 3TM RTC SYSTEM (IN-VITRO DIAG.SYST.)

K930685 is an FDA 510(k) clearance for TECHNICON H* 3TM RTC SYSTEM (IN-VITRO D..., manufactured by Heraeus Kulzer, Inc.. The device is a Class 2 Hematology device with product code GKL cleared through the Traditional 510(k) pathway after a 132-day FDA review.

K930685 · Heraeus Kulzer, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1993
Decision
132d
Days
Class 2
Risk

K930685 is an FDA 510(k) clearance for the TECHNICON H* 3TM RTC SYSTEM (IN-VITRO DIAG.SYST.). Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Heraeus Kulzer, Inc. (Tarrytown, US). The FDA issued a Cleared decision on June 22, 1993 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Heraeus Kulzer, Inc. devices

FDA 510(k) Submission Details - K930685

510(k) Number K930685 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 1993
Decision Date June 22, 1993
Days to Decision 132 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 113d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKL Device Classification - Class 2, Special Controls

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 99
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K930685.
RETICULOCYTE METHOD
K954607 · Bayer Corp. · Aug 1996
YELLOW IRIS URINALYSIS WORKSTATION W/IRISCOPE BODY FLUID ANALYSIS CAPABILITY
K954006 · Intl. Remote Imaging Systems · Mar 1996
COULTER Z 1
K952308 · Coulter Corp. · Oct 1995
QBC HEMACAN HEMATOLOGY SYSTEM
K923121 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1992
SYSMEX(TM) R-3000 AUTOMATED RETICULOCYTE ANALYZER
K912494 · Toa Medical Electronics USA, Inc. · Sep 1991
SYSMEX F-810
K910849 · Toa Medical Electronics USA, Inc. · Jul 1991